All In Biotech

Drug Trial Radar · NCT07633119

A Phase Ⅲ Clinical Study of SNA02-48 Injection

A Multicenter, Randomized, Double-Blind, Active-Controlled Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of SNA02-48 Injection in Populations With High-Risk Tetanus Exposure

Last checked: Nov 19, 2026Latest source record: Jun 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingPhase 3. Randomized with 600 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

600

Planned (sponsor's estimate)

Start

Jun 28, 2026

Primary completion

Mar 31, 2027

Study completion May 31, 2027

Sponsor

Sponsor type
Industry
First posted
Jun 8, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this clinical trial is to compare the efficacy and safety of SNA02-48 injection with Human Tetanus Immunoglobulin (HTIG) for tetanus prophylaxis.

Conditions

  • Tetanus

Interventions

  • SNA02-48Drug

    IM gluteal injection

  • Human tetanus immunoglobulin (HTIG)Drug

    IM gluteal injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The proportion of participants with an increase of anti-tetanus neutralizing antibody titers (∆ titers) over protective level.Time frame: Baseline up to 12 hours after receipt of study drug

Locations

30 sites in 1 country. Site status is shown where the registry gives one.

  • Taihe County People's Hospital

    Fuyang, Anhui, China

  • The Second Affiliated Hospital of Anhui Medical University

    Hefei, Anhui, China

  • Peking University First Hospital

    Beijing, Beijing Municipality, China

  • Peking University People's Hospital

    Beijing, Beijing Municipality, China

  • Beijing Tiantan Hospital Affiliated to Capital Medical University

    Beijing, Beijing Municipality, China

  • Peking Union Medical College Hospital

    Beijing, Beijing Municipality, China

  • The First Affiliated Hospital of Guangzhou Medical University

    Guangzhou, Guangdong, China

  • The Third Affiliated Hospital of Guangzhou Medical University

    Guangzhou, Guangdong, China

  • Guangzhou Eighth People's Hospital, Guangzhou Medical University

    Guangzhou, Guangdong, China

  • The Fifth Affiliated Hospital of Southern Medical University

    Guangzhou, Guangdong, China

  • Shenzhen Second People's Hospital

    Shenzhen, Guangdong, China

  • Longhua District People's Hospital of Shenzhen

    Shenzhen, Guangdong, China

  • Liuzhou Worker's Hospital

    Liuzhou, Guangxi, China

  • Liuzhou People's Hospital

    Liuzhou, Guangxi, China

  • Affiliated Hospital of Zunyi Medical University

    Zunyi, Guizhou, China

  • The Second Hospital of Hebei Medical University

    Shijiazhuang, Hebei, China

  • Wuhan Union Hospital

    Wuhan, Hubei, China

  • Affiliated Nanhua Hospital, University of South China

    Hengyang, Hunan, China

  • Taizhou People's Hospital

    Taizhou, Jiangsu, China

  • Affiliated Hospital of Yangzhou University

    Yangzhou, Jiangsu, China

  • Affiliated Hospital of Jiangsu University

    Zhenjiang, Jiangsu, China

  • The Second Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, China

  • Pingxiang People's Hospital

    Pingxiang, Jiangxi, China

  • Weifang People's Hospital

    Weifang, Shandong, China

  • Linfen Central Hospital

    Linfen, Shanxi, China

  • Shanxi Bethune Hospital

    Taiyuan, Shanxi, China

  • Yuncheng Central Hospital, Shanxi Province

    Yuncheng, Shanxi, China

  • West China Hospital, Sichuan University

    Chengdu, Sichuan, China

  • Lishui Central Hospital

    Lishui, Zhejiang, China

  • Ningbo Medical Center Li Huili Hospital

    Ningbo, Zhejiang, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.